Abstract: A new family of rare-earth silicate compositions and the synthetic methods used to prepare them. The materials have open-framework structures and are characterized by their ion-exchange properties. They are represented by the following empirical formula: Ar+pMs+1-xM?t+xSinOm where A is an exchangeable cation such as sodium, M is at least one element selected from the group of rare-earth elements, and M? is a framework metal having a valence of +2, +3, +4, or +5. The rare-earth silicate materials have utility in various cation-exchange applications such as dialysis and removal of toxic metals from the gastrointestinal tract.

Abstract: A process for removing Pb2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchange composition to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchange composition. The ion exchange compositions are represented by the following empirical formula: AmTiaNb1-aSixOy having either the pharmacosiderite, sitinakite, pharmacosiderite-sitinakite intergrowth topologies or mixtures thereof. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

Abstract: A process for removing Pb2+ toxins from bodily fluids involves contacting the bodily fluid with an ion exchange composition to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchange composition. The ion exchange compositions are represented by the following empirical formula: AmTiaNb1-aSixOy having either the pharmacosiderite, sitinakite, pharmacosiderite-sitinakite intergrowth topologies or mixtures thereof. There are also compositions comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

Abstract: A process for removing Co2+, Pb2+, Cd2+ and Cr3+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchange composition to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchange composition. The ion exchange compositions are represented by the following empirical formula: AmZraTibSncMdSixOy. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

Abstract: A process for removing Sr2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The ion exchangers are represented by the following empirical formula: AmZraTibSncMdSixOy. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

Abstract: A process for removing Hg2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with a titanium metallate ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The titanium metallate ion exchangers are represented by the following empirical formula: AmTiNbaSixOy. A composition is provided with the combination of the titanium metallate ion exchanger and bodily fluids or dialysis solutions. Also, provided is an apparatus comprising a matrix and the titanium metallate ion exchanger.

Abstract: A process for removing Pb2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchange composition to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchange composition. The ion exchange compositions are represented by the following empirical formula: AmTiaNb1-aSixOy having either the pharmacosiderite, sitinakite, pharmacosiderite-sitinakite intergrowth topologies or mixtures thereof. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

Abstract: A process for removing Pb2+, Hg2+, K+ and NH4+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchange composition to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchange composition. The ion exchange compositions are represented by the following empirical formula: Ar+pMs+1-xM?t+xSinOm A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

Abstract: A process for removing Pb2+, Hg2+ and other heavy metal toxins from bodily fluids is disclosed. The process involves treating a patient with a small molecule heavy metal chelator to remove these toxins from bones and soft tissue cells into the blood or other bodily fluid. Then an ion exchange composition is used to ion exchange the heavy metal toxins from bodily fluids either within the body or by treatment outside the body such as by dialysis. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

Abstract: A new family of rare-earth silicate compositions and the synthetic methods used to prepare them. The materials have open-framework structures and are characterized by their ion-exchange properties. They are represented by the following empirical formula: Ar+pMs+1-xM?t+xSinOm where A is an exchangeable cation such as sodium, M is at least one element selected from the group of rare-earth elements, and M? is a framework metal having a valence of +2, +3, +4, or +5. The rare-earth silicate materials have utility in various cation-exchange applications such as dialysis and removal of toxic metals from the gastrointestinal tract.

Abstract: A process for removing Sr2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The ion exchangers are represented by the following empirical formula: AmZraTibSncMdSixOy. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

Abstract: A process for removing Hg2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with a titanium metallate ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The titanium metallate ion exchangers are represented by the following empirical formula: AmTiNbaSixOy. A composition is provided with the combination of the titanium metallate ion exchanger and bodily fluids or dialysis solutions. Also, provided is an apparatus comprising a matrix and the titanium metallate ion exchanger.

Abstract: A process for removing Co2+, Pb2+, Cd2+ and Cr3+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchange composition to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchange composition. The ion exchange compositions are represented by the following empirical formula: AmZraTibSncMdSixOy. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

Abstract: A composition, process and apparatuses for removal of one or more contaminant anions from water are provided. In an embodiment, the process includes treating the water with a composition comprising a layered metal hydroxy salt, wherein the layered metal hydroxy salt is a compound comprising (a) a metal (b) a framework hydroxide, and (c) a replaceable anion.

Abstract: A composition, process and apparatuses for removal of one or more contaminant anions from water are provided. In an embodiment, the process includes treating the water with a composition comprising a layered metal hydroxy salt, wherein the layered metal hydroxy salt is a compound comprising (a) a metal (b) a framework hydroxide, and (c) a replaceable anion.

Abstract: A process for removing Hg2+ ions from a liquid stream is disclosed. The process involves contacting the liquid stream with specified UOP Zeolitic Materials. These molecular sieves are particularly effective in removing Hg2+ ions from aqueous streams even in the presence of Mg2+ and Ca2+ ions. The effective molecular sieves have an intermediate range of Si/Al ratios between about 2 and 20 and preferably between 3 and 10.

Abstract: Aluminas with increased surface acidity, methods of making the same, and methods for using the same are provided. In an exemplary embodiment, a method for increasing the surface acidity of an alumina material includes providing an alumina starting material, and processing the alumina starting material under hydrothermal conditions in the presence of one or more organic acids to generate a hydrothermally treated alumina. In this embodiment, the one or more organic acids includes a polyprotic organic acid with a pKa value of about 0 to about 10, and the resulting hydrothermally treated alumina has increased surface acidity relative to the alumina starting material.

Abstract: A process for removing Hg2+ ions from a liquid stream is disclosed. The process involves contacting the liquid stream with specified ion-exchangers based on manganese oxides and metallomanganese oxides of the form An+wM3+xMn1-xO2 where A can be cations such as Na+ or Mg2+, M3+ can be metals such as Fe3+ or Co3+, and the TIC, the theoretical ion exchange capacity per framework metal atom, varies from 0.08 to 0.25. These ion-exchangers are particularly effective in removing Hg2+ ions from aqueous streams even in the presence of Mg2+ and Ca2+ ions.

Abstract: A new family of crystalline microporous metallophosphates designated AlPO-67 has been synthesized. These metallophosphates are represented by the empirical formula R+rMm2+EPxSiyOz where R is an organoammonium cation such as the ETMA+ or DEDMA+, M is a framework metal alkaline earth or transition metal of valence 2+, and E is a trivalent framework element such as aluminum or gallium. The AlPO-67 compositions exhibit the LEV framework topology and have catalytic properties for carrying out various hydrocarbon conversion processes and separation properties for separating at least one component.

Abstract: A new family of crystalline microporous silicometallophosphates designated MAPSO-64 and modified forms thereof have been synthesized. These silicometallophosphates are represented by the empirical formula R+rMm2+EPxSiyOz where R is an organoammonium cation such as ETMA+ or DEDMA+, M is an alkaline earth or transition metal cation of valence 2+, and E is a trivalent framework element such as aluminum or gallium. The MAPSO-64 compositions are characterized by a BPH framework topology and have catalytic properties for carrying out various hydrocarbon conversion processes, and separation properties for separating at least one component.